Identification of a panel of serum protein markers in early stage of sepsis and its validation in a cohort of patients.

[1]  Christopher W Seymour,et al.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[2]  T. Rea,et al.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[3]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[4]  J. Casado-Vela,et al.  High‐throughput proteomic characterization of plasma rich in growth factors (PRGF–Endoret)‐derived fibrin clot interactome , 2015, Journal of tissue engineering and regenerative medicine.

[5]  Nguyen T. Nguyen,et al.  Plasma Glycoproteomics Reveals Sepsis Outcomes Linked to Distinct Proteins in Common Pathways* , 2015, Critical care medicine.

[6]  Z. Tothova,et al.  Hemophagocytic Syndrome and Critical Illness , 2015, Journal of intensive care medicine.

[7]  P. Nawroth,et al.  Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis? , 2015, World journal of experimental medicine.

[8]  S. Ku,et al.  Early Diagnosis of Sepsis Using Serum Hemoglobin Subunit Beta , 2015, Inflammation.

[9]  Yoichi Kase,et al.  Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation , 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  Chuan-Qing Wang,et al.  Elevated serum ApoE levels are associated with bacterial infections in pediatric patients. , 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[11]  H. Møller,et al.  Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients , 2014, PloS one.

[12]  R. A. Robinson,et al.  The role of proteomics in understanding biological mechanisms of sepsis , 2014, Proteomics. Clinical applications.

[13]  C. Downey,et al.  The clinical utility of fibrin-related biomarkers in sepsis , 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[14]  M. Nagarkatti,et al.  Role of cytokines as a double-edged sword in sepsis. , 2013, In vivo.

[15]  Jonathan Cohen,et al.  Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care , 2013, Critical Care.

[16]  P. Ward,et al.  The inflammatory response in sepsis. , 2013, Trends in immunology.

[17]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock 2012 , 2013, Critical care medicine.

[18]  Stanley Lemeshow,et al.  Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. , 2012, The Lancet. Infectious diseases.

[19]  John Doyle,et al.  Sepsis: Something old, something new, and a systems view. , 2012, Journal of critical care.

[20]  J. Laine,et al.  Apoptosis markers soluble Fas (sFas), Fas Ligand (FasL) and sFas/FasL ratio in patients with bacteremia: a prospective cohort study. , 2012, The Journal of infection.

[21]  W. Liles,et al.  Clinical utility of biomarkers of endothelial activation in sepsis-a systematic review , 2012, Critical Care.

[22]  S. Weitzman.  Approach to hemophagocytic syndromes. , 2011, Hematology. American Society of Hematology. Education Program.

[23]  Sanjeeva Srivastava,et al.  Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead , 2011, Proteomics.

[24]  J. Gallimore,et al.  A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection , 2010, BMC pediatrics.

[25]  A. El Beshlawy,et al.  Study of protein C, protein S, and antithrombin III in newborns with sepsis , 2010, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[26]  Antoine M. van Oijen,et al.  Real-time single-molecule observation of rolling-circle DNA replication , 2009, Nucleic acids research.

[27]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[28]  Iain Mackenzie,et al.  Sepsis: definition, epidemiology, and diagnosis , 2007, BMJ : British Medical Journal.

[29]  M. Mann,et al.  In-gel digestion for mass spectrometric characterization of proteins and proteomes , 2006, Nature Protocols.

[30]  M. Kurrer,et al.  Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis , 2006, European journal of haematology.

[31]  S. Opal,et al.  High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: Efficacy and safety* , 2006, Critical care medicine.

[32]  Tao Liu,et al.  Utilizing human blood plasma for proteomic biomarker discovery. , 2005, Journal of proteome research.

[33]  M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.

[34]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[35]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[36]  S. Urieli-Shoval,et al.  Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states , 2000, Current opinion in hematology.

[37]  C. Croce,et al.  Characterization of a cDNA clone encoding human filaggrin and localization of the gene to chromosome region 1q21. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  T. van der Poll,et al.  Severe sepsis and septic shock. , 2013, The New England journal of medicine.

[39]  Daniel Faria,et al.  Serum proteomics signature of cystic fibrosis patients: a complementary 2-DE and LC-MS/MS approach. , 2011, Journal of proteomics.

[40]  G. Chiocchia,et al.  Clusterin : A Multifacet Protein at the Crossroad of Inflammation and Autoimmunity , 2009 .

[41]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[42]  T. van der Poll,et al.  Disseminated intravascular coagulation. , 1999, Thrombosis and haemostasis.